Business Standard

Mangalam Drugs and Organics standalone net profit declines 50.77% in the September 2022 quarter

Image

Capital Market

Sales decline 6.86% to Rs 106.37 crore

Net profit of Mangalam Drugs and Organics declined 50.77% to Rs 2.23 crore in the quarter ended September 2022 as against Rs 4.53 crore during the previous quarter ended September 2021. Sales declined 6.86% to Rs 106.37 crore in the quarter ended September 2022 as against Rs 114.20 crore during the previous quarter ended September 2021. ParticularsQuarter EndedSep. 2022Sep. 2021% Var.Sales106.37114.20 -7 OPM %7.9412.06 -PBDT5.8910.79 -45 PBT3.138.29 -62 NP2.234.53 -51

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 12 2022 | 8:02 AM IST

Explore News